User-agent: *
Disallow: /wp-admin
Disallow: /wp-includes
Disallow: /wp-content/
Disallow: */trackback
Disallow: */comment
Disallow: /thanks-newsletter-completed
Disallow: /imprint
Disallow: /add-a-company
Disallow: /thanks-newsletter
Disallow: /cookie-policy
Disallow: /company/evotec
Disallow: /company/glycomar
Disallow: /company/pluriomics
Disallow: /company/atlanthera
Disallow: /company/dcprime
Disallow: /compagny/hookipa_biotech_ag
Allow: /wp-content/uploads/
Allow: /site.xml

User-agent: Googlebot-Mobile
Disallow: /tag/

User-agent: Googlebot-News
Disallow: /groningen-antibiotic-resistant-bacteria
Disallow: /dbv-technologies-viaskin-patch-la-results-allergy-biotech-interview
Disallow: /interview-gensight-biotech-startup-blindness-gene-therapy
Disallow: /new-peptide-technology-against-cancer-bags-25-million-euros
Disallow: /immuno-oncology-europe-poll
Disallow: /oryzon-interview-carlos-buesa
Disallow: /immuno-oncology-biomarkers-animal-models
Disallow: /academia-biotech-careers-startups
Disallow: /ysios-interview-karen-wagner
Disallow: /biotem-4th-generation-therapeutic-antibodies